Deanna Gerber
New York University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Deanna Gerber.
Gynecologic Oncology | 2018
J. Lee; Lindsay Gubernick; Allison L. Brodsky; Julia Fehniger; Douglas A. Levine; Deanna Gerber; Shabnam Asgari; Anna Cantor; Jessica Martineau; Ophira Ginsburg; John A. Smith; Bhavana Pothuri
OBJECTIVES Lynch syndrome (LS) accounts for the majority of inherited endometrial cancers (EC), and the identification of probands presents a unique opportunity to treat and prevent multiple cancers. The diagnosis of EC can provide the indication for women with specific risk factors to undergo genetic testing (GT). We sought to evaluate genetic counseling referrals (GCR) and subsequent GT rates in an ethnically diverse group of high-risk women. METHODS All women diagnosed with EC between 2011 and 2016 were identified. Risk factors for LS including age, family and personal histories of Lynch-related cancers and loss of tumor mismatch repair (MMR) protein expression were identified from laboratory and medical records. Standard two-sided statistical tests were used. RESULTS Of 583 women diagnosed with EC, 184 (31.6%) were found to have at least one high-risk characteristic for LS. Among these high-risk women, 58% were given GCR and resulting in only 35% undergoing GT. Ten of the 65 high-risk women who had GT (15.4%) were diagnosed with Lynch syndrome, and all ten met high-risk criteria. Two women of Asian race had tumors exhibiting retained MMR protein expression despite germline testing demonstrating Lynch syndrome. CONCLUSIONS Many high-risk women do not receive GCR despite a high rate of germline mutations among these women. Improving GCR among high-risk women will lead to more subsequent GT to identify more Lynch syndrome families and prevent additional cancers. Among our ethnically diverse cohort, two women diagnosed with LS had retained MMR protein expression. GCR should be offered to women who possess high-risk characteristics despite normal MMR protein expression.
Journal of Clinical Oncology | 2018
Olivia R Khouri; Deanna Gerber; J. Lee; Julia Fehniger; Leslie R. Boyd; Bhavana Pothuri
Journal of Clinical Oncology | 2018
Deanna Gerber; Fanny Dao; Narciso Olvera; Nolan Piccola; Douglas A. Levine
Journal of Clinical Oncology | 2018
Anne Olsen; Deanna Gerber; Olivia R Khouri; J. Lee; Julia Fehniger; Bhavana Pothuri
Journal of Clinical Oncology | 2018
Sarah S. Lee; Melissa K. Frey; Deanna Gerber; Zachary Schwartz; Jessica Martineau; Kathleen Lutz; Erin Reese; Emily Dalton; Anne Olsen; Bhavana Pothuri; Leslie R. Boyd; John P. Curtin; S.V. Blank
Journal of Clinical Oncology | 2018
J. Lee; Allison L. Brodsky; Deanna Gerber; Julia Fehniger; Shabnam Asgari; Anna Cantor; Jessica Martineau; John A. Smith; Ophira Ginsburg; Bhavana Pothuri
Journal of Clinical Oncology | 2018
Deanna Gerber; Olivia R Khouri; Meghan Smith; J. Lee; Julia Fehniger; James A. Grifo; Bhavana Pothuri; Leslie R. Boyd
Gynecologic Oncology | 2018
J. Lee; Allison L. Brodsky; N. Madden; K. Musselman; K. Huang; S.K. Jain; Deanna Gerber; Julia Fehniger; Bhavana Pothuri
Gynecologic Oncology | 2018
Deanna Gerber; A. Olsen; J. Lee; Julia Fehniger; Shabnam Asgari; Anna Cantor; Jessica Martineau; Ophira Ginsburg; John A. Smith; Douglas A. Levine; Bhavana Pothuri
Gynecologic Oncology | 2018
J. Lee; Deanna Gerber; Julia Fehniger; John P. Curtin; Leslie R. Boyd